Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2013
12/27/2013WO2013192609A1 Mesoporous oxide nanoparticles and methods of making and using same
12/27/2013WO2013192566A1 Itraconazole compositions and dosage forms, and methods of using the same
12/27/2013WO2013192493A1 Nanoparticles of indirubin, derivatives thereof and methods of making and using same
12/27/2013WO2013192360A1 Anti-cd70 antibody drug conjugates
12/27/2013WO2013192131A1 Incretin receptor ligand polypeptide fc-region fusion polypeptides and conjugates with altered fc-effector function
12/27/2013WO2013192034A2 Sanitizer compositions comprising alcohol and an antimicrobial efficacy enhancer
12/27/2013WO2013191998A1 Electrochemically degradable polymers
12/27/2013WO2013191459A1 Polyvalent pneumococcal polysaccharide-protein conjugate composition
12/27/2013WO2013191319A1 Method for preparing granule or pill containing extract in high concentration
12/27/2013WO2013191293A1 Pharmaceutical composition containing loxoprofen
12/27/2013WO2013191187A1 Adhesive preparation composition obtained by blending drug, organic solvent, lipophilic ointment base, and powder
12/27/2013WO2013191158A1 Percutaneous absorption promoter and skin patch comprising same
12/27/2013WO2013191128A1 Skin patch
12/27/2013WO2013190292A2 Novel process for preparation of antibody conjugates and novel antibody conjugates
12/27/2013WO2013190272A1 Conjugation reagents
12/27/2013WO2013190148A1 Peptide-silica hybrid materials
12/27/2013WO2013189800A1 Cisatracurium and beta-cyclodextrin derivative compositions
12/27/2013WO2013189776A1 Active ingredient-containing solid dispersions based on diethylaminoethyl methacrylate copolymers
12/27/2013WO2013189663A1 Conjugate of a photosensitiser and chitosan and uses thereof
12/27/2013WO2013189477A1 Emulsion for pharmaceutical use and method for the production thereof
12/27/2013WO2013189472A1 Emulsion for pharmaceutical use and method for the production thereof
12/27/2013WO2013189287A1 Use of interferon in treatment/prevention of tumors resistant to conventional anti-tumor therapy
12/27/2013WO2013189282A1 Polypeptide-medicine-slow-releasing microsphere preparation and preparation method therefor
12/27/2013WO2013188979A1 Mucoadhesive nanoparticle delivery system
12/27/2013WO2013136346A3 Taste masking pharmaceutical orally dissolving strips of lornoxicam
12/27/2013WO2013049328A9 Di-aliphatic substituted pegylated lipids
12/27/2013CA2877648A1 Polyvalent pneumococcal polysaccharide-protein conjugate composition
12/27/2013CA2877363A1 Incretin receptor ligand polypeptide fc-region fusion polypeptides and conjugates with altered fc-effector function
12/27/2013CA2877124A1 Anti-cd70 antibody drug conjugates
12/27/2013CA2877121A1 Sanitizer compositions comprising alcohol and an antimicrobial efficacy enhancer
12/27/2013CA2877051A1 Mucoadhesive nanoparticle delivery system
12/27/2013CA2876977A1 Natural combination hormone replacement formulations and therapies
12/27/2013CA2876968A1 Soluble estradiol capsule for vaginal insertion
12/27/2013CA2876964A1 Progesterone formulations
12/27/2013CA2876947A1 Transdermal hormone replacement therapies
12/27/2013CA2876934A1 Electrochemically degradable polymers
12/27/2013CA2876909A1 Itraconazole compositions and dosage forms, and methods of using the same
12/27/2013CA2876904A1 Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
12/27/2013CA2876365A1 Novel process for preparation of antibody conjugates and novel antibody conjugates
12/27/2013CA2875454A1 Composition for patch preparation comprising drug, organic solvent, lipophilic mass base, and powder
12/26/2013US20130345321 Genipin cross-linked fibrin gels
12/26/2013US20130345320 Active-Ingredient-Containing Solid Dispersions Based on Diethylaminoethyl Methacrylate Copolymers
12/26/2013US20130345319 Polymer hydrogel adhesives formed with multiple crosslinking mechanisms at physiologic ph
12/26/2013US20130345309 Malic acid-enriched plant extract
12/26/2013US20130345305 Powder emulsifier
12/26/2013US20130345298 Multi-Arm Polymeric Prodrug Conjugates of Cabazitaxel-Based Compounds
12/26/2013US20130345274 Allantoin-containing skin cream
12/26/2013US20130345265 Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient
12/26/2013US20130345260 High Viscosity Liquid Controlled Delivery System and Medical or Surgical Device
12/26/2013US20130345236 Pharmaceutical compositions providing enhanced drug concentrations
12/26/2013US20130345151 Preparation for oral administration comprises quercetin glycoside and a water based solvent extract of cartilage containing chondroitin sulfate
12/26/2013US20130345149 Silicone-based ophthalmic formulations
12/26/2013US20130345119 Multimeric antimicrobial peptide complex which is displayed on cell surface
12/26/2013US20130344160 Implantable bio-resorbable polymer charged with fragile macromolecules
12/26/2013US20130344159 Implantable swellable bio-resorbable polymer
12/26/2013US20130344157 Enhancement of the efficacy of therapeutic proteins
12/26/2013US20130344152 Peroxide dispersions
12/26/2013US20130344144 Low flush niacin formulation
12/26/2013US20130344134 Inhibitors of cyclic amp phosphodiesterases
12/26/2013US20130344127 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
12/26/2013US20130344098 CAT Allergen Conjugates and Uses Thereof
12/26/2013US20130344027 Multi-functional polymeric materials and their uses
12/26/2013US20130344023 Polymer-active agent conjugates
12/25/2013EP2676680A1 Use of hydrophobin polypeptides as penetration enhancers
12/25/2013EP2676679A2 Formulations which stabilize and inhibit precipitation of immunogenic compositions
12/25/2013EP2676677A1 Highly concentrated anti-cd40 antibody pharmaceutical preparation
12/25/2013EP2676663A2 Transdermal delivery system containing galantamine or salts thereof
12/25/2013EP2676661A2 Orally administered sustained-release triple-layer pill containing tamsulosin or pharmaceutically acceptable salt thereof
12/25/2013EP2675485A2 Anti-mucin antibodies for early detection and treatment of pancreatic cancer
12/25/2013EP2675482A2 Carrier peptides for cell delivery
12/25/2013EP2675481A1 Cytotoxic benzodiazepine derivatives and methods of preparation
12/25/2013EP2675480A1 Methods of preparation of conjugates
12/25/2013EP2675479A1 Cytotoxic benzodiazepine derivatives
12/25/2013EP2675471A1 Hsa-related compositions and methods of use
12/25/2013EP2675454A1 Methods for controlling pain in equines using a transdermal solution of fentanyl
12/25/2013EP2569267B1 Improved methods for preparing squalene
12/25/2013EP2526930B1 Vitamin formulation
12/25/2013EP2512515B1 Pharmaceutical composition for treatment of dry eye syndrome
12/25/2013EP2397487B1 Short-chain cationic polyamino acid and use thereof
12/25/2013EP2359827B1 Adhesive material containing 5-methyl-1-phenyl-2-(1h)-pyridone
12/25/2013EP2269589B1 Ion binding polymers and uses thereof
12/25/2013EP2198890B1 Combinatorial libraries of monomer domains
12/25/2013EP2186789B1 Method of producing reduced coenzyme q10 and method of stabilizing the same
12/25/2013CN103476801A Cellulose-based nanoparticles for drug delivery
12/25/2013CN103476433A Improved immunotherapy
12/25/2013CN103476432A Process for producing aqueous solution containing fat-soluble substance
12/25/2013CN103476431A Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof
12/25/2013CN103476419A Pharmaceutical compositions of iron for oral administration
12/25/2013CN103476404A Transdermal compositions comprising an active agent layer and an active agent conversion layer
12/25/2013CN103476399A Drug delivery particles and method for producing same
12/25/2013CN103476398A Menthol liquids composition
12/25/2013CN103476396A Suspension type topical formulations comprising cyclic depsipeptide
12/25/2013CN103468662A Recombined human hyaluronidase, production and purification method and preparations thereof, use method and application
12/25/2013CN103467781A Method for preparing porous polysaccharide microsphere
12/25/2013CN103467755A Medicinal sustained-release hydrogel as well as preparation method and application thereof
12/25/2013CN103467753A Preparation method of amphipathic hydroxyethyl starch-grafted polylactic acid nano-micelle
12/25/2013CN103467746A Amphiphilic polymer and preparing method thereof
12/25/2013CN103467729A Polyethylene glycol-poly amino acid-polyester triblock polymer, preparation method and use thereof
12/25/2013CN103467604A Sleep-inducing peptide fusion protein and its application
12/25/2013CN103467592A Interferon alpha mutant and polyethylene glycol derivate thereof
1 ... 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 ... 1712